{"transactions":[{"id":737462,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":36709,"kind":"person","name":"Bondurant Michael Breen","position":1,"cik":"0002140335","reported_name":"Bondurant Michael Breen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-15T20:30:24.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":800000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":800000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001731122-26-000860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000860/ownership.xml","form_type":"4"}},{"id":742773,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39584,"kind":"person","name":"Fore Thomas Butler","position":1,"cik":"0001715594","reported_name":"Fore Thomas Butler","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:54.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":500000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-26-000836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000836/ownership.xml","form_type":"4"}},{"id":742772,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:39.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":500000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-26-000835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000835/ownership.xml","form_type":"4"}},{"id":743014,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39641,"kind":"person","name":"Francis Knuettel II","position":1,"cik":"0001433316","reported_name":"Francis Knuettel II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:23.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":500000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-26-000834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433316/000173112226000834/ownership.xml","form_type":"4"}},{"id":742771,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39582,"kind":"person","name":"Cobb Brady James","position":1,"cik":"0002112459","reported_name":"Cobb Brady James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:11.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":925000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":925000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":925000},"source":{"system":"sec-edgar","filing":"0001731122-26-000833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000833/ownership.xml","form_type":"4"}},{"id":742872,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39603,"kind":"person","name":"Scott Martin P","position":1,"cik":"0001306996","reported_name":"Scott Martin P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:00.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":700000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":700000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001731122-26-000832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1306996/000173112226000832/ownership.xml","form_type":"4"}},{"id":1010452,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39584,"kind":"person","name":"Fore Thomas Butler","position":1,"cik":"0001715594","reported_name":"Fore Thomas Butler","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-10-31T20:15:22.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"By TBF Holdings LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"TBF Holdings LLC is an entity which the Reporting Person controls."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001461/ownership.xml","form_type":"4"}},{"id":1015741,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-10-20T20:20:47.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001406/ownership.xml","form_type":"4"}},{"id":1015740,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-20T20:15:20.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters."},{"field":"security","element":"securityTitle","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":15000,"derivative":{"exercise_price":13.6,"expiration_date":"2027-04-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001731122-25-001405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001405/ownership.xml","form_type":"4"}},{"id":1015739,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-20T20:15:20.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001731122-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001405/ownership.xml","form_type":"4"}},{"id":1018278,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Warrants","published_at":"2025-10-15T20:20:08.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001386/ownership.xml","form_type":"4"}},{"id":1018277,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-15T20:18:12.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The amount beneficially owned will not reconcile to prior Form 4s due to a scriveners error."}],"balance_after":38053,"source":{"system":"sec-edgar","filing":"0001731122-25-001385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001385/ownership.xml","form_type":"4"}},{"id":1018295,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-10-15T20:16:36.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112225001383/ownership.xml","form_type":"4"}},{"id":1018752,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74270,"kind":"person","name":"Devereux William T","position":1,"cik":"0002089296","reported_name":"Devereux William T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-15T16:16:52.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date."},{"field":"security","element":"securityTitle","label":"F2","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.04,"expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001731122-25-001384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089296/000173112225001384/ownership.xml","form_type":"4"}},{"id":1019247,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74301,"kind":"person","name":"Meissner William R.","position":1,"cik":"0001489090","reported_name":"Meissner William R.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CMO"}}],"security":"Warrants","published_at":"2025-10-14T16:15:28.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489090/000173112225001374/ownership.xml","form_type":"4"}},{"id":1020407,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74270,"kind":"person","name":"Devereux William T","position":1,"cik":"0002089296","reported_name":"Devereux William T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-10-10T16:31:10.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."}],"balance_after":1000000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001731122-25-001372","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089296/000173112225001372/ownership.xml","form_type":"4"}},{"id":1526498,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":91434,"kind":"person","name":"Ivancsits Julius Paul","position":1,"cik":"0002022414","reported_name":"Ivancsits Julius Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options","published_at":"2024-05-06T18:22:04.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025."}],"balance_after":750000,"derivative":{"exercise_price":0.33,"expiration_date":"2034-04-26","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-24-000741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022414/000173112224000741/ownership.xml","form_type":"4"}},{"id":1589084,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":50384,"kind":"person","name":"Paglia John Kenneth","position":1,"cik":"0001627832","reported_name":"Paglia John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2024-03-07T22:30:37.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure."},{"field":"shares","element":"transactionShares","label":"F1","text":"The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest."},{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company."}],"balance_after":600000,"derivative":{"exercise_price":0.5275,"expiration_date":"2034-02-26","underlying":"Common stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001731122-24-000375","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627832/000173112224000375/ownership.xml","form_type":"4"}},{"id":1759684,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":108976,"kind":"person","name":"Dhalla Fatima","position":1,"cik":"0001913908","reported_name":"Dhalla Fatima","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock options","published_at":"2023-10-16T21:54:23.000Z","date":"2022-05-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were issued in connection with serving as the interim chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. All 35,000 options vested on May 2, 2022."}],"balance_after":35000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-05-02","underlying":"Common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-23-001907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223001907/ownership.xml","form_type":"4"}},{"id":1815916,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":110872,"kind":"person","name":"Wall Ronald Charles","position":1,"cik":"0001925305","reported_name":"Wall Ronald Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options","published_at":"2023-08-03T17:41:52.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":222000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving as the chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 166,500 of the options vested on May 2, 2023 and 55,500 options will vest on May 2, 2024."}],"balance_after":333000,"derivative":{"exercise_price":1.21,"expiration_date":"2033-05-02","underlying":"Common stock","underlying_shares":222000},"source":{"system":"sec-edgar","filing":"0001731122-23-001343","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223001343/ownership.xml","form_type":"4"}},{"id":1851511,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-06-16T15:19:18.000Z","date":"2023-06-16","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":1.01,"value":7070.0,"ownership":{"direct":true},"balance_after":1386000,"source":{"system":"sec-edgar","filing":"0001731122-23-001152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223001152/ownership.xml","form_type":"4"}},{"id":1884153,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-19T18:06:42.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By SNS Universal Solutions, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle."}],"balance_after":125000,"derivative":{"exercise_price":1.26,"expiration_date":"2033-05-01","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000987/ownership.xml","form_type":"4"}},{"id":1893096,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":23223,"kind":"person","name":"McDonough Peter J","position":1,"cik":"0001680728","reported_name":"McDonough Peter J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-15T20:31:08.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"expiration_date":"2033-04-05","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000936/ownership.xml","form_type":"4"}},{"id":1893182,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-15T20:30:50.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"expiration_date":"2033-04-05","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112223000935/ownership.xml","form_type":"4"}},{"id":1893704,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-15T16:30:33.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"expiration_date":"2033-04-05","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112223000934/ownership.xml","form_type":"4"}},{"id":1919402,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-04-14T14:34:56.000Z","date":"2023-04-14","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":1.149,"value":13788.0,"ownership":{"direct":true},"balance_after":1379000,"source":{"system":"sec-edgar","filing":"0001731122-23-000653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000653/ownership.xml","form_type":"4"}},{"id":1920173,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-04-13T16:48:06.000Z","date":"2023-04-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.1699,"value":11699.0,"ownership":{"direct":true},"balance_after":1367000,"source":{"system":"sec-edgar","filing":"0001731122-23-000644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000644/ownership.xml","form_type":"4"}},{"id":1920172,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-04-13T16:48:06.000Z","date":"2023-04-13","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":1.169,"value":8183.0,"ownership":{"direct":true},"balance_after":1357000,"source":{"system":"sec-edgar","filing":"0001731122-23-000644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000644/ownership.xml","form_type":"4"}},{"id":2040010,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":110872,"kind":"person","name":"Wall Ronald Charles","position":1,"cik":"0001925305","reported_name":"Wall Ronald Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2023-01-31T20:18:24.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the Options vested on May 2, 2022. One-fourth of the Options will vest on May 2, 2023, May 2, 2024, and May 2, 2025."}],"balance_after":111000,"derivative":{"exercise_price":2.31,"expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0001731122-23-000105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000105/ownership.xml","form_type":"4"}},{"id":2229538,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-16T21:04:09.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":1000,"price":1.69,"value":1690.0,"ownership":{"direct":true},"balance_after":1327070,"source":{"system":"sec-edgar","filing":"0001731122-22-001089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001089/ownership.xml","form_type":"4"}},{"id":2229537,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-16T21:04:09.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":1000,"price":1.67,"value":1670.0,"ownership":{"direct":true},"balance_after":1326070,"source":{"system":"sec-edgar","filing":"0001731122-22-001089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001089/ownership.xml","form_type":"4"}},{"id":2229536,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-16T21:04:09.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":1000,"price":1.69,"value":1690.0,"ownership":{"direct":true},"balance_after":1325070,"source":{"system":"sec-edgar","filing":"0001731122-22-001089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001089/ownership.xml","form_type":"4"}},{"id":2229535,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-16T21:04:09.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":685,"price":1.83,"value":1253.55,"ownership":{"direct":true},"balance_after":1324070,"source":{"system":"sec-edgar","filing":"0001731122-22-001089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001089/ownership.xml","form_type":"4"}},{"id":2229534,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-16T21:04:09.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":315,"price":1.82,"value":573.3,"ownership":{"direct":true},"balance_after":1323385,"source":{"system":"sec-edgar","filing":"0001731122-22-001089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001089/ownership.xml","form_type":"4"}},{"id":2239935,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-07T13:09:35.000Z","date":"2022-06-03","kind":"purchase","acquired":true,"shares":1000,"price":2.07,"value":2070.0,"ownership":{"direct":true},"balance_after":1323070,"source":{"system":"sec-edgar","filing":"0001731122-22-001037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001037/ownership.xml","form_type":"4"}},{"id":2239934,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-07T13:09:35.000Z","date":"2022-06-03","kind":"purchase","acquired":true,"shares":1000,"price":2.04,"value":2040.0,"ownership":{"direct":true},"balance_after":1322070,"source":{"system":"sec-edgar","filing":"0001731122-22-001037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001037/ownership.xml","form_type":"4"}},{"id":2250900,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":1000,"price":2.04,"value":2040.0,"ownership":{"direct":true},"balance_after":1321070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250899,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":1000,"price":2.03,"value":2030.0,"ownership":{"direct":true},"balance_after":1320070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250898,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":2000,"price":2.12,"value":4240.0,"ownership":{"direct":true},"balance_after":1319070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250897,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":2000,"price":1.95,"value":3900.0,"ownership":{"direct":true},"balance_after":1317070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250896,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":2000,"price":1.95,"value":3900.0,"ownership":{"direct":true},"balance_after":1315070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250895,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":2000,"price":1.99,"value":3980.0,"ownership":{"direct":true},"balance_after":1313070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2250894,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-31T20:05:33.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":1000,"price":1.94,"value":1940.0,"ownership":{"direct":true},"balance_after":1311070,"source":{"system":"sec-edgar","filing":"0001731122-22-001019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222001019/ownership.xml","form_type":"4"}},{"id":2304977,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-04-05T17:25:54.000Z","date":"2021-05-16","kind":"grant","acquired":true,"shares":333333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022."}],"balance_after":333333,"derivative":{"exercise_price":2.25,"expiration_date":"2026-05-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-22-000676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112222000676/ownership.xml","form_type":"4"}},{"id":2312616,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-04-01T01:42:09.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-22-000655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112222000655/ownership.xml","form_type":"4"}},{"id":2312520,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-04-01T01:39:38.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":530000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":530000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":530000},"source":{"system":"sec-edgar","filing":"0001731122-22-000653","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222000653/ownership.xml","form_type":"4"}},{"id":2312519,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":23223,"kind":"person","name":"McDonough Peter J","position":1,"cik":"0001680728","reported_name":"McDonough Peter J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-04-01T01:37:25.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-22-000651","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112222000651/ownership.xml","form_type":"4"}},{"id":2313088,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-03-31T21:44:44.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-22-000657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112222000657/ownership.xml","form_type":"4"}},{"id":3003756,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":500000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-09","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003755,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":500000,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-09","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003754,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":1000000,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-16","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003753,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333333,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-15","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003752,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333333,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-15","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003751,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":74241,"kind":"person","name":"Nistico Robert","position":1,"cik":"0001797597","reported_name":"Nistico Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Chairman"}}],"security":"Warrants (Right to Buy )","published_at":"2020-10-19T22:34:57.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333334,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-16","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":333334},"source":{"system":"sec-edgar","filing":"0001731122-20-001063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001063/ownership.xml","form_type":"4"}},{"id":3003749,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":23223,"kind":"person","name":"McDonough Peter J","position":1,"cik":"0001680728","reported_name":"McDonough Peter J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:32:51.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333333,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-15","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-20-001061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001061/ownership.xml","form_type":"4"}},{"id":3003748,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":23223,"kind":"person","name":"McDonough Peter J","position":1,"cik":"0001680728","reported_name":"McDonough Peter J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:32:51.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333333,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-15","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-20-001061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001061/ownership.xml","form_type":"4"}},{"id":3003747,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":23223,"kind":"person","name":"McDonough Peter J","position":1,"cik":"0001680728","reported_name":"McDonough Peter J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:32:51.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":333334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":333334,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-16","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":333334},"source":{"system":"sec-edgar","filing":"0001731122-20-001061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112220001061/ownership.xml","form_type":"4"}},{"id":3003834,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166666,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-15","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}},{"id":3003833,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166667,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-15","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}},{"id":3003832,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166667,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-16","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}},{"id":3003760,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":145867,"kind":"person","name":"Huge Dean Scott","position":1,"cik":"0001550918","reported_name":"Huge Dean Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T18:28:04.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":100000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-09","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001731122-20-001057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1550918/000173112220001057/ownership.xml","form_type":"4"}},{"id":3003759,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":145867,"kind":"person","name":"Huge Dean Scott","position":1,"cik":"0001550918","reported_name":"Huge Dean Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T18:28:04.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":100000,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-09","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001731122-20-001057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1550918/000173112220001057/ownership.xml","form_type":"4"}},{"id":3003758,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":145867,"kind":"person","name":"Huge Dean Scott","position":1,"cik":"0001550918","reported_name":"Huge Dean Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T18:28:04.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":100000,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-09","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001731122-20-001057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1550918/000173112220001057/ownership.xml","form_type":"4"}},{"id":3003757,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":145867,"kind":"person","name":"Huge Dean Scott","position":1,"cik":"0001550918","reported_name":"Huge Dean Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-19T18:28:04.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":140000,"price":0.75,"value":105000.0,"ownership":{"direct":false,"nature":"By DSH Development Group, Inc."},"balance_after":727315,"source":{"system":"sec-edgar","filing":"0001731122-20-001057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1550918/000173112220001057/ownership.xml","form_type":"4"}},{"id":3462481,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":156032,"kind":"person","name":"West Michael J.","position":1,"cik":"0001465846","reported_name":"West Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-12T15:36:39.000Z","date":"2019-06-21","kind":"sale","acquired":false,"shares":8000000,"price":0.034,"value":272000.0,"ownership":{"direct":true},"balance_after":344000,"source":{"system":"sec-edgar","filing":"0001079973-19-000397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465846/000107997319000397/ownership.xml","form_type":"4"}}]}